Robert Marcus
Stock Analyst at JP Morgan
(0)
# 3161
Out of 5,291 analysts
32
Total ratings
47.06%
Success rate
1.03%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Penumbra | Maintains: Overweight | 230 285 | 266.95 | 6.76% | 3 | Feb 19, 2025 | |
Integra Lifesciences | Upgrades: Neutral | 75 | 21.68 | 245.94% | 2 | Dec 17, 2021 | |
Becton, Dickinson | Downgrades: Neutral | 265 | 227.36 | 16.56% | 6 | Aug 6, 2021 | |
Glaukos | Downgrades: Underweight | 50 | 101.97 | -50.97% | 2 | Oct 8, 2020 | |
TransMedics Gr | Downgrades: Neutral | 15 | 68.47 | -78.09% | 2 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 19 | n/a | n/a | 5 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 39 | 0.05 | 77900% | 1 | Aug 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 48 57 | 31.78 | 79.36% | 2 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 90 100 | 5.85 | 1609.4% | 9 | May 6, 2020 |